Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Companies that are able to build their patent portfolios are rewarded with a longer duration of high-margin patent-protected sales.
This chart shows the pharmaceutical companies which listed the most drug patents last year.
The companies with the most drug patents listed last year are Novartis, Sanofi Aventis Us, Galen Specialty, Janssen Pharms, Apotex Technologies, Fresenius Kabi Usa, Gilead, Bayer Hlthcare, Fougera Pharms, and Merck.